dijous, 23 de març del 2017

Trump proposes higher FDA fees for drug, medical device FDA registrants

Emergo GroupBy Stewart Eisenhart, Emergo Group

US Food and Drug Administration user fee increases in the Trump Administration’s proposed 2018 federal budget would disproportionately impact smaller medical device companies, as these firms make up the majority of the US medical device industry.

Get the full story here at the Emergo Group’s blog.

The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of MassDevice.com or its employees.

The post Trump proposes higher FDA fees for drug, medical device FDA registrants appeared first on MassDevice.



from MassDevice http://ift.tt/2naqLmu

Cap comentari:

Publica un comentari a l'entrada